{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:33:22Z","timestamp":1788910402459,"version":"build-2803163510"},"reference-count":7,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:p>Patients with lysosomal storage diseases may require modifications to standard drug desensitization protocols; personalized medicine as well as development of new treatment options are needed.<\/jats:p>","DOI":"10.1542\/peds.2021-052648","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T03:11:25Z","timestamp":1642734685000},"source":"Crossref","is-referenced-by-count":11,"title":["Successful Elosulfase Alfa Desensitization Protocol in a Patient With Morquio A Syndrome"],"prefix":"10.1542","volume":"149","author":[{"given":"Ver\u00f3nica C.","family":"D\u00edaz Vidal","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine, Houston, Texas"},{"name":"Division of Immunology, Allergy, and Retrovirology, Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gillispie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Aranda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Federal University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Anvari","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine, Houston, Texas"},{"name":"Division of Immunology, Allergy, and Retrovirology, Texas Children\u2019s Hospital, Houston, Texas"},{"name":"William T. Shearer Center for Human Immunobiology, Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"2022020117430235100_B1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13023-014-0173-x","article-title":"A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases","volume":"9","author":"Leadley","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2022020117430235100_B2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International Morquio A Registry: clinical manifestation and natural course of Morquio A disease","volume":"30","author":"Monta\u00f1o","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"2022020117430235100_B3","article-title":"Mucopolysaccharidosis type IVA","volume-title":"GeneReviews","author":"Regier","year":"1993\u20132021"},{"key":"2022020117430235100_B4","first-page":"141","article-title":"Morquio A syndrome: diagnosis and current and future therapies","volume":"12","author":"Tomatsu","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"issue":"4","key":"2022020117430235100_B5","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaip.2017.02.020","article-title":"Successful desensitization of elosulfase alfa-induced anaphylaxis in a pediatric patient with Morquio syndrome","volume":"5","author":"Guvenir","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"2022020117430235100_B6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/pai.13049","article-title":"Anaphylaxis after Elosulfase A infusion: omalizumab as coadjuvant for enzyme replacement therapy desensitization","volume":"30","author":"Arroabarren","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"2022020117430235100_B7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jaip.2015.11.012","article-title":"Diagnosis and management of infusion-related hypersensitivity reactions to enzyme replacement therapy for lysosomal diseases: The role of desensitization","volume":"4","author":"Aranda","year":"2016","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-052648\/1255723\/peds_2021052648.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-052648\/1255723\/peds_2021052648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T12:43:23Z","timestamp":1643719403000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/149\/2\/e2021052648\/184541\/Successful-Elosulfase-Alfa-Desensitization"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":7,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1,21]]},"published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-052648","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"article-number":"e2021052648"}}